PCSS Office-Based Treatment for Opioid Use Disorders Webinar - Saturday, 3/13/2021

Includes a Live Event on 03/13/2021 at 8:00 AM (EST)

As of the requirements to obtain the waiver, physicians without specified experience must complete not less than 8 hours of training. A total of 8 hours of training is federally mandated for physicians and a total of 24 hours of training is mandated for NPs and PAs.

The first half of the training is a 4.25-hour live webcast. The second half of the course is a 3.75-hour computer-based study. An examination on the computer study must be successfully completed within 30 days of the webinar session as part of the process to obtain a waiver for prescribing buprenorphine.

Instructions on how to log on to the second half of the course will be provided via email, ONLY to those who complete the 4.25-hour live webcast in its entirety. Please note that in order to be eligible for the waiver to prescribe Buprenorphine, you must complete a total of 8 hours consisting of the live webcast session (4.25-hours) and the online self-study session and exam (3.75-hours) within 30 days of the live webcast session. The AOAAM cannot verify completion of the webinar session if less than 4.25 hours are attended. Should you not attend for the entire session, you will have to retake the entire webinar again on a different date in order to get credit. Please be aware that it is MANDATORY that you are able to view and hear the presentation and participate in the interactive polling questions in order for the AOAAM to verify your attendance. The combined live webcast and online self-study training will provide 8 hours to be applied toward obtaining the waiver to prescribe buprenorphine in office-based treatment of opioid dependence. Physicians who complete this course will meet the training qualification under the new law. For NPs and PAs, an additional 16-hours of training will be required for waiver eligibility.

 

CONTINUING MEDICAL EDUCATION: This session has been approved for 4.25 AOA Category 1-A CME credits, providing all requirements have been met. It has also been approved for 4.25 AAFP Prescribed Credit hours, which are eligible for the AMA’s Physician Recognition Award Credit. Participants are required to attend the entire 4.25-hour session, participate in the interactive polling questions and complete the post-test with a passing grade of 70% in order to be eligible for CME credit. CME certificates will become available once all components of the training are fulfilled.

For More Information and FREE training and educational resources visit: www.pcssnow.org.

Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Stephen A. Wyatt, DO

Medical Director, Addiction Medicine Carolinas HealthCare System Charlotte, NC

Dr. Wyatt is a graduate Chicago College of Osteopathic Medicine. He practiced Emergency Medicine in Michigan for 13 years before entering a psychiatric residency at University Hospitals of Cleveland, Case Western Reserve University in 1993.  He then entered a NIDA Clinical Research Fellowship in the Yale School of Medicine in Addiction Psychiatry. His primary interest and research has been in co-morbid problems, adolescents, and education.  He sits on a variety of Federal committees on substance use disorders including the Physician Clinical Support System, PCSS, for Medication Assisted Treatment.  He served on the expert panel for office based use of Buprenorphine for the Federation of State Medical Boards. He is the Past President of the Connecticut Society of Addiction Medicine and the American Osteopathic Academy of Addiction Medicine. He was a Board Co-chair for the Connecticut Department of Mental Health and Addiction Services   He has been active in all levels of medical education in advocating for greater understanding and improvement in treatment of substance use problems in the provision of care.

This program has been approved for 4.25 AOA Category 1-A CME credits (live webcast session only) providing all requirements have been met. It has also been approved for 4.25 AAFP Prescribed Credit hours, which are eligible for the AMA’s Physician Recognition Award Credit. Participants are required to attend the entire 4.25-hour session, participate in the interactive polling questions and complete the post-test with a passing grade of 70% in order to be eligible for CME credit.

CME certificates will be provided 30 days after the training date.

Key:

Complete
Failed
Available
Locked
Pre-Test
10 Questions  |  1 attempt  |  0/10 points to pass
10 Questions  |  1 attempt  |  0/10 points to pass In order to be CME compliant, a pre-test is required. You will not be graded on this quiz but will be required for CME eligibility. Once completed, regardless of score, you will be allowed to participate in the webinar.
You must register to access.
PCSS Office-Based Treatment for Opioid Use Disorders Webinar -3/13/2021
03/13/2021 at 8:00 AM (EST)   |  300 minutes
03/13/2021 at 8:00 AM (EST)   |  300 minutes This is PART 1 of the waiver eligibility training. As of the requirements to obtain the waiver, physicians without specified experience must complete not less than 8 hours of training. A total of 8 hours of training is federally mandated for physicians. For NPs and PAs, an additional 16-hours of training will be required for waiver eligibility. NOTE: This training has a starting time of 8:00 am Eastern Time Zone. Please check your time zone for start time. Please download the Zoom app prior to training. https://zoom.us/ent?zcid=2582 The first half of the training is a 4.25-hour live webcast. The second half of the course is a 3.75-hour computer-based study. An examination on the computer study must be successfully completed within 30 days of the webinar session as part of the process to obtain a waiver for prescribing buprenorphine. Instructions on how to log on to the second half of the course will be provided via email, ONLY to those who complete the 4.25-hour live webcast in its entirety. The AOAAM cannot verify completion of the webinar session if less than 4.25 hours are attended. Please be aware that it is MANDATORY that you are able to view and hear the presentation and participate in the interactive polling questions in order for the AOAAM to verify your attendance. PHONE ONLY PARTICIPATION DOES NOT QUALIFY FOR PARTICIPATION CREDIT. The combined live webcast and online self-study training will provide the required 8 hours to be applied toward obtaining the waiver to prescribe buprenorphine in office-based treatment of opioid dependence. Physicians who complete this course will meet the training qualification under the new law. NPs and PAs will require an additional 16-hours of training. Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Access to Part 2 will be emailed to you after successful participation of Part 1 is verified. Please note that this may take up to 48 hours.
You must register to access.
Certificate of Attendance
No credits available  |  Certificate available
No credits available  |  Certificate available This certificate certifies that you have successfully completed Part 1 of the training and have earned 4.25-hours of attendance credit to be applied towards the total required training of 8-hours. You are eligible to advance to Part 2 for the remaining 3.75-hours of training. A follow-up email will be sent to you within 48 hours of the training date with the link and directions on how to access Part 2. If you wish to receive CME credits for the training, please complete the remaining components of Part 1 which include a survey and post-webinar quiz.
You must register to access.
OBOT Survey / 4.25-Hour
8 Questions
8 Questions As a CME accredited sponsor, it is required that an evaluation be provided to you in order to be compliant with CME regulations. Once you complete the survey, a certificate will be available for download/print.
You must register to access.
Post-Test
10 Questions  |  3 attempts  |  7/10 points to pass
10 Questions  |  3 attempts  |  7/10 points to pass As an accredited sponsor and to meet CME compliance, a post-test is required for CME eligibility. You will need a minimum score of 70% in order to be eligible for CME.
You must register to access.
Certificate of Attendance and CME
Up to 4.25 medical credits available  |  Certificate available
Up to 4.25 medical credits available  |  Certificate available The Certificate of Attendance and CME is your combined certificate verifying the training hours from Part 1, along with your CME credits earned. The Certificate of Attendance and CME verifies that the specified hours of training were completed and can be applied toward obtaining the waiver in the office-based treatment of opioid use disorders. Furthermore, please use this certificate to report CME to your respective accrediting board. If you are a D.O., the AOAAM will report your CME credits to the AOA for you. Please allow 90 days for the AOAAM to complete this process.
You must register to access.